Agenda
Tuesday, September 10
10.00
10.00
Exploiting Aging Pathways to extend healthspan
Brian Kennedy, PhD., NUS, Singapore, SG
10:20
10:20
Danica Chen, Ph.D., the University of California, Berkeley, USA
10:40
10:40
Matt Kaeberlein, Ph.D., the University of Washington, USA
11:00
11:00
Break
11:30
11:30
Aubrey de Grey, Ph.D, AgeX / SENS Research Foundation, California, USA
11:50
11:50
Translational Strategies to Prevent Sarcopenia through Targeted Cellular Nutrition
Jerome N. Feige, Ph.D
12:10
12:10
Cornelis Calkhoven, Ph.D, ERIBA, Groningen, The Netherlands
12:45
12:45
Lunch break & Industry Symposia
14:00
14:00
Drivers of neurotoxicity in prion diseases
Adriano Aguzzi, the University of Zurich, Zurich, Switzerland
14:20
14:20
David Rubinsztein, PhD, FMedSci, Professor, CIMR Cambridge Institute for Medical Research, Cambridge, UK
14:40
14:40
Adam Antebi, Ph.D, Max Planck Institute for Biology of Ageing, Cologne, Germany
15:00
15:00
Break
15:30
15:30
Thorsten Hoppe, Ph.D., the University of Cologne, Cologne, Germany
15:50
15:50
Ana Martin-Villalba, M.D - Ph.D, DKFZ German Cancer Research Center, Heidelberg, Germany
16:10
16:10
Anne Bertolotti, Ph.D., FMedSci., MRC Laboratory of Molecular Biology, Cambridge, UK
Wednesday, September 11
10.00
10.00
Mechanisms of intracellular DNA sensing through the cGAS-STING pathway
Andrea Ablasser, EPFL, Lausanne, Switzerland
10:20
10:20
Pandomics: a drug discovery tool for aging and oncology
Ivan Ozerov, Ph.D, Insilico Medicine, Hong Kong
10:40
10:40
Vadim Gladyshev, Ph.D, Harvard Medical School, Boston, USA
11:00
11:00
Break
11:30
11:30
Morten Scheibye-Knudsen, M.D., Ph.D, Center for Healthy Aging, Copenhagen, Denmark
11:50
11:50
Nir Barzilai, M.D., Ph.D, Albert Einstein College of Medicine, New York, United States
12:10
12:10
Is anti-aging drug discovery becoming a reality
Alexey Moskalev, Engelhardt Institute of Molecular Biology, Moscow, Russia
12:20
12:20
Identification and application of gene expression signatures associated with lifespan extension
Alexander Tyshkovskiy, Ph.D., Harvard Medical School
12:45
12:45
Lunch break & Industry Symposia
14:00
14:00
Pekka Katajisto, Ph.D, University of Helsinki, Helsinki, Finland
14:20
14:20
Martin Borch Jensen, Ph.D, Gordian Biotechnology San Francisco United States
14:40
14:40
Panel discussion
15:00
15:00
Break
15:30
15:30
EMBO Plenary session 5 (on Aging)
Thursday, September 12
9.00
9.00
EMBO Plenary session 6 (on AI)
10.15
10.15
Break
10:45
10:45
Deep learning in drug discovery for aging research
Quentin Vanhaelen, Ph.D, Insilico Medicine, Hong Kong
11.05
11.05
Martin-Immanuel Bittner, MD DPhil, Arctoris, Oxford, UK
11:45
11:45
Break
12:20
12:20
Ketogenic diet to delay brain aging
Michael A. Petr, University of Copenhagen, Copenhagen, Denmark
12:40
12:40
Andrei Gudkov, Ph.D., D.Sci., Roswell Park Comprehensive Cancer Center
13:00
13:00
Lunch break & Industry Symposia
14:30
14:50
14:50
Conquering Aging: AI Opportunity for the Pharmaceutical Industry
Unmesh Lal, Frost&Sullivan, Germany
15:00
15:00
Longevity VC panel (DKV, Barclays)
Unmesh Lal, Frost&Sullivan, Germany − Moderator
Cecile Cai, 36KR Beijing, China
Dmitry Kaminsky, Deep Knowledge Ventures, London, UK
Michael Antonov, Oculus, San Francisco, USA
Patrick Burgermeister, Kizoo Technology Capital, Basel, Switzerland
Angela Tyrrell, Longevity Leaders, London, UK